Diabetes, Vol 40, Issue 12 1659-1668, Copyright © 1991 by American Diabetes Association

ARTICLES

Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs

MJ Pagliassotti, SR Myers, MC Moore, DW Neal and AD Cherrington
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615.

To examine the relationship between the magnitude of the negative arterial-portal glucose gradient and net hepatic glucose uptake, two groups of 42-h fasted, conscious dogs were infused with somatostatin, to suppress endogenous insulin and glucagon secretion, and the hormones were replaced intraportally to create hyperinsulinemia (3- to 4-fold basal) and basal glucagon levels. The hepatic glucose load to the liver was doubled and different negative arterial-portal glucose gradients were established by altering the ratio between portal and peripheral vein glucose infusions. In protocol 1 (n = 6) net hepatic glucose uptake was 42.2 +/- 6.7, 35.0 +/- 3.9, and 33.3 +/- 4.4 mumol.kg-1.min-1 at arterial-portal plasma glucose gradients of -4.1 +/- 0.9, -1.8 +/- 0.4, and -0.8 +/- 0.1 mM, respectively. In protocol 2 (n = 6) net hepatic glucose uptake was 26.1 +/- 2.8 and 12.2 +/- 1.7 mumol.kg-1.min-1 at arterial-portal plasma glucose gradients of -0.9 +/- 0.2 and -0.4 +/- 0.1 mM, respectively. No changes in the hepatic insulin or glucose loads were evident within a given protocol. Although net hepatic glucose uptake was lower in protocol 2 when compared with protocol 1 (26.1 +/- 2.8 vs. 33.3 +/- 4.4 mumol.kg-1.min-1) in the presence of a similar arterial-portal plasma glucose gradient (-0.9 vs. -0.8 mM) the difference could be attributed to the hepatic glucose load being lower in protocol 2 (i.e., hepatic fractional glucose extraction was not significantly different) primarily as a result of lower hepatic blood flow. In conclusion, in the presence of fixed hepatic glucose and insulin loads, the magnitude of the negative arterial-portal glucose gradient can modify net hepatic glucose uptake in vivo.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. P. Vahl, M. Tauchi, T. S. Durler, E. E. Elfers, T. M. Fernandes, R. D. Bitner, K. S. Ellis, S. C. Woods, R. J. Seeley, J. P. Herman, et al. Glucagon-Like Peptide-1 (GLP-1) Receptors Expressed on Nerve Terminals in the Portal Vein Mediate the Effects of Endogenous GLP-1 on Glucose Tolerance in Rats Endocrinology, October 1, 2007; 148(10): 4965 - 4973. [Abstract] [Full Text] [PDF]

				S.-S. Chen, C. J Torres-Sanchez, N. Hosein, Y. Zhang, D. B. Lacy, C. Chang, and O. P. McGuinness Route-dependent effect of nutritional support on liver glucose uptake Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1319 - R1327. [Abstract] [Full Text] [PDF]

				S. Cardin, M. J. Pagliassotti, M. C. Moore, D. S. Edgerton, M. Lautz, B. Farmer, D. W. Neal, and A. D. Cherrington Vagal cooling and concomitant portal norepinephrine infusion do not reduce net hepatic glucose uptake in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R742 - R748. [Abstract] [Full Text] [PDF]

				N. Ogihara, W. Kawamura, K. Kasuga, Y. Hayashi, H. Arakawa, and M. Kikuchi Characterization of the portal signal during 24-h glucose delivery in unrestrained, conscious rats Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E932 - E940. [Abstract] [Full Text] [PDF]

				M. C. Moore, S. Cardin, D. S. Edgerton, B. Farmer, D. W. Neal, M. Lautz, and A. D. Cherrington Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E226 - E233. [Abstract] [Full Text] [PDF]

				M. C. Moore, M. J. Burish, B. Farmer, D. W. Neal, C. Pan, and A. D. Cherrington Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E845 - E853. [Abstract] [Full Text] [PDF]

				F. Zangeneh, R. Basu, P. Shah, P. Arora, M. Camilleri, and R. A. Rizza Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E280 - E286. [Abstract] [Full Text] [PDF]

				N. Ogihara, S. Ebihara, W. Kawamura, M. Okamoto, T. Sakai, K. Takiguchi, T. Morita, R. Uchida, Y. Matsuyama, Y. Hayashi, et al. Characterization of the portal signal in a nonsteady hyperglycemic state in conscious dogs Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E148 - E155. [Abstract] [Full Text] [PDF]

				P. Georg, A. Kautzky-Willer, K. Mahdjoobian, A. Hofer, R. Prager, G. Pacini, and B. H. Ludvik Influence of Metabolic Control on Splanchnic Glucose Uptake, Insulin Sensitivity, and the Time Required for Glucose Absorption in Patients With Type 1 Diabetes Diabetes Care, November 1, 2002; 25(11): 2042 - 2047. [Abstract] [Full Text] [PDF]

				G. W. Cline, K. Johnson, W. Regittnig, P. Perret, E. Tozzo, L. Xiao, C. Damico, and G. I. Shulman Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats Diabetes, October 1, 2002; 51(10): 2903 - 2910. [Abstract] [Full Text] [PDF]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, W. F. Schwenk, and R. A. Rizza Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E259 - E266. [Abstract] [Full Text] [PDF]

				M. Bajaj, R. Berria, T. Pratipanawatr, S. Kashyap, W. Pratipanawatr, R. Belfort, K. Cusi, L. Mandarino, and R. A. DeFronzo Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E346 - E352. [Abstract] [Full Text] [PDF]

				R. Burcelin, A. Da Costa, D. Drucker, and B. Thorens Glucose Competence of the Hepatoportal Vein Sensor Requires the Presence of an Activated Glucagon-Like Peptide-1 Receptor Diabetes, August 1, 2001; 50(8): 1720 - 1728. [Abstract] [Full Text] [PDF]

				A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity Diabetes, June 1, 2001; 50(6): 1351 - 1362. [Abstract] [Full Text]

				A. Vella, P. Shah, R. Basu, A. Basu, M. Camilleri, F. W. Schwenk, J. J. Holst, and R. A. Rizza Effect of Glucagon-Like Peptide-1(7-36)-Amide on Initial Splanchnic Glucose Uptake and Insulin Action in Humans With Type 1 Diabetes Diabetes, March 1, 2001; 50(3): 565 - 572. [Abstract] [Full Text]

				M. C. Moore, P.-S. Hsieh, D. W. Neal, and A. D. Cherrington Nonhepatic response to portal glucose delivery in conscious dogs Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1271 - E1277. [Abstract] [Full Text] [PDF]

				P.-S. Hsieh, M. C. Moore, D. W. Neal, and A. D. Cherrington Importance of the hepatic arterial glucose level in generation of the portal signal in conscious dogs Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E284 - E292. [Abstract] [Full Text] [PDF]

				S. H. Kreisman, A. Manzon, S. J. Nessim, J. A. Morais, R. Gougeon, S. J. Fisher, M. Vranic, and E. B. Marliss Glucoregulatory responses to intense exercise performed in the postprandial state Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E786 - E793. [Abstract] [Full Text] [PDF]

				M. C. Moore, P.-S. Hsieh, P. J. Flakoll, D. W. Neal, and A. D. Cherrington Net Hepatic Gluconeogenic Amino Acid Uptake in Response to Peripheral versus Portal Amino Acid Infusion in Conscious Dogs J. Nutr., December 1, 1999; 129(12): 2218 - 2224. [Abstract] [Full Text]

				S. Cardin, M. Emshwiller, P. A. Jackson, W. L. Snead, J. Hastings, D. S. Edgerton, and A. D. Cherrington Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats J Appl Physiol, October 1, 1999; 87(4): 1470 - 1475. [Abstract] [Full Text] [PDF]

				P.-S. Hsieh, M. C. Moore, B. Marshall, M. J. Pagliassotti, B. Shay, D. Szurkus, D. W. Neal, and A. D. Cherrington The head arterial glucose level is not the reference site for generation of the portal signal in conscious dogs Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E678 - E684. [Abstract] [Full Text] [PDF]

				P. Galassetti, C. A. Chu, D. W. Neal, G. W. Reed, D. H. Wasserman, and A. D. Cherrington A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E126 - E134. [Abstract] [Full Text] [PDF]

				P. Galassetti, R. H. Coker, D. B. Lacy, A. D. Cherrington, and D. H. Wasserman Prior exercise increases net hepatic glucose uptake during a glucose load Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1022 - E1029. [Abstract] [Full Text] [PDF]

				M. C. Moore, P.-S. Hsieh, P. J. Flakoll, D. W. Neal, and A. D. Cherrington Differential effect of amino acid infusion route on net hepatic glucose uptake in the dog Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E295 - E302. [Abstract] [Full Text] [PDF]

				P.-S. Hsieh, M. C. Moore, D. W. Neal, and A. D. Cherrington Hepatic glucose uptake rapidly decreases after removal of the portal signal in conscious dogs Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E987 - E992. [Abstract] [Full Text] [PDF]

				A. Manzon, S. J. Fisher, J. A. Morais, L. Lipscombe, M.-C. Guimond, S. J. Nessim, R. J. Sigal, J. B. Halter, M. Vranic, and E. B. Marliss Glucose infusion partially attenuates glucose production and increases uptake during intense exercise J Appl Physiol, August 1, 1998; 85(2): 511 - 524. [Abstract] [Full Text] [PDF]

				P. Galassetti, M. Shiota, B. A. Zinker, D. H. Wasserman, and A. D. Cherrington A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E101 - E111. [Abstract] [Full Text] [PDF]